Accelerated Biologic Aging and Risk for Sepsis and Organ Failure Following Trauma

加速生物衰老以及创伤后败血症和器官衰竭的风险

基本信息

  • 批准号:
    8118557
  • 负责人:
  • 金额:
    $ 9.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-01 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Guided by an adapted version of the Vulnerable Populations Conceptual Framework which incorporates concepts from Psychoneuroimmunology, this project will examine bio-behavioral mechanisms associated with chronic stress and accelerated biologic aging (i.e. premature cell death and system decline) which could adversely affect susceptibility to sepsis and organ failure following trauma (i.e., acute, life-threatening injuries). Trauma kills more than 13 million people annually. Sepsis and organ failure are the leading causes of in- hospital trauma deaths and are affected by baseline inflammation and poor inflammatory response, yet few data exist to explain differences in vulnerability to these deadly outcomes. Research has shown that African Americans (AAs) and persons of low socioeconomic status (SES) have nearly twice the rates of sepsis and organ dysfunction as Caucasians. Low SES has been associated with baseline inflammation, a finding related to organ dysfunction. Chronic stress may be a contributing factor. AAs and persons of low SES report chronic stress, which has been linked to accelerated biologic aging via telomerase activity. Declining levels of telomerase have also been associated with advanced age, a known risk factor for sepsis and organ failure. Chronic stress has been linked with physiologic "wear and tear" (i.e. allostatic load) on immune system function, resulting in changes similar that which are seen with advanced age. Thus, the specific aims of this project are that 1) accelerated biologic aging is a significant predisposing factor contributing to susceptibility to sepsis and organ failure following trauma and 2) chronic stress is a significant predisposing factor contributing to increased baseline inflammation and differences in the magnitude of the inflammatory response. Trauma patients who are 1) 18-44 years old; 2) have injury severity scores >15; and 3) times of <1 hour from injury to Emergency Department admission (n =300) will be recruited. Accelerated biologic aging will be operationally defined by low telomerase activity. Chronic stress will be operationally defined by high scores on the Life Events and Difficulties Schedule and high hair cortisol. Participants will be excluded for 1) blood transfusion or infection < 2 weeks prior to admission; 2) steroid, NSAID, or salicylate use for > 1 month prior to admission; 3) pre-existing organ disease; 4) cancer, autoimmune conditions, or pregnancy; 5) spinal cord injury; or missing data. Primary outcome variables are susceptibility to sepsis and organ failure, baseline inflammation status, and magnitude of the inflammatory response to trauma indicated by the 1) overall response and 2) peak magnitude of inflammatory cytokines and immature neutrophils in plasma from ED admission through ICU length of stay. Secondary variables will also be analyzed, including socio-demographic and lifestyle factors. Knowledge gained will inform future studies to prevent these often-fatal outcomes. This research is consistent with the National Institute of Nursing Research mission, which supports research that incorporates the best of clinical and basic science to develop unique approaches to disease prevention. PUBLIC HEALTH RELEVANCE: Trauma, defined as acute, life-threatening injuries, is the leading cause of death for individuals aged 18-44 years. Accelerated (i.e., premature) aging and chronic stress before trauma could explain why some individuals have poor outcomes in the intensive care unit after trauma, such as sepsis and organ failure. Information from this research will help us better understand why different populations of trauma patients have different outcomes, and could be used in future studies aimed at prevention.
描述(由申请人提供):在弱势群体概念框架的改编版本的指导下,该项目将研究与慢性应激和加速生物衰老(即细胞过早死亡和系统衰退)相关的生物行为机制,这些机制可能对创伤(即急性,危及生命的伤害)后败血症和器官衰竭的易感性产生不利影响。每年有超过1300万人死于创伤。败血症和器官衰竭是院内创伤死亡的主要原因,并受基线炎症和不良炎症反应的影响,但很少有数据解释对这些致命结果的易感程度的差异。研究表明,非洲裔美国人(AAs)和低社会经济地位(SES)的人患败血症和器官功能障碍的比例几乎是白种人的两倍。低SES与基线炎症有关,这一发现与器官功能障碍有关。慢性压力可能是一个促成因素。as和低SES的人报告慢性应激,这与通过端粒酶活性加速的生物衰老有关。端粒酶水平的下降也与老年有关,这是败血症和器官衰竭的已知危险因素。慢性压力与免疫系统功能的生理“磨损”(即适应负荷)有关,导致与老年相似的变化。因此,该项目的具体目标是:1)加速的生物衰老是导致创伤后败血症和器官衰竭易感性的重要易感因素;2)慢性应激是导致基线炎症增加和炎症反应强度差异的重要易感因素。18-44岁的创伤患者;2)损伤严重程度评分>15分;3)从受伤到进入急诊室的时间<1小时(n =300)。在操作上,加速的生物老化将由端粒酶活性降低来定义。慢性压力将被定义为生活事件和困难时间表的高分和高皮质醇。1)入院前2周内输血或感染者将被排除;2)入院前1个月使用类固醇、非甾体抗炎药或水杨酸盐;3)既往器官疾病;4)癌症、自身免疫性疾病或怀孕;5)脊髓损伤;或者缺少数据。主要结局变量是败血症和器官衰竭的易感性,基线炎症状态,以及创伤炎症反应的程度,由1)总体反应和2)从ED入院到ICU住院时间血浆中炎症细胞因子和未成熟中性粒细胞的峰值大小指示。次要变量也将被分析,包括社会人口和生活方式因素。所获得的知识将为未来的研究提供信息,以预防这些通常致命的后果。这项研究与国家护理研究研究所的使命是一致的,该研究所支持将最好的临床和基础科学相结合的研究,以开发独特的疾病预防方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELIZABETH Grooms NESMITH其他文献

ELIZABETH Grooms NESMITH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELIZABETH Grooms NESMITH', 18)}}的其他基金

Accelerated Biologic Aging and Risk for Sepsis and Organ Failure Following Trauma
加速生物衰老以及创伤后败血症和器官衰竭的风险
  • 批准号:
    8290454
  • 财政年份:
    2010
  • 资助金额:
    $ 9.37万
  • 项目类别:
Accelerated Biologic Aging and Risk for Sepsis and Organ Failure Following Trauma
加速生物衰老以及创伤后败血症和器官衰竭的风险
  • 批准号:
    7990128
  • 财政年份:
    2010
  • 资助金额:
    $ 9.37万
  • 项目类别:
Inflammation and Sub-Clinical Renal Damage in Cocaine-Dependent African Americans
可卡因依赖的非裔美国人的炎症和亚临床肾损伤
  • 批准号:
    7835557
  • 财政年份:
    2009
  • 资助金额:
    $ 9.37万
  • 项目类别:
Inflammation and Sub-Clinical Renal Damage in Cocaine-Dependent African Americans
可卡因依赖的非裔美国人的炎症和亚临床肾损伤
  • 批准号:
    7641863
  • 财政年份:
    2009
  • 资助金额:
    $ 9.37万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.37万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.37万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 9.37万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.37万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 9.37万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.37万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.37万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.37万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 9.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 9.37万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了